1
Por Grivas, P., Khaki, A.R., Wise-Draper, T.M., French, B., Hennessy, C., Hsu, C.-Y., Shyr, Y., Li, X., Choueiri, T.K., Painter, C.A., Peters, S., Rini, B.I., Thompson, M.A., Mishra, S., Rivera, D.R., Acoba, J.D., Abidi, M.Z., Bakouny, Z., Bashir, B., Bekaii-Saab, T., Berg, S., Bernicker, E.H., Bilen, M.A., Bindal, P., Bishnoi, R., Bouganim, N., Bowles, D.W., Cabal, A., Caimi, P.F., Chism, D.D., Crowell, J., Curran, C., Desai, A., Dixon, B., Doroshow, D.B., Durbin, E.B., Elkrief, A., Farmakiotis, D., Fazio, A., Fecher, L.A., Flora, D.B., Friese, C.R., Fu, J., Gadgeel, S.M., Galsky, M.D., Gill, D.M., Glover, M.J., Goyal, S., Grover, P., Gulati, S., Gupta, S., Halabi, S., Halfdanarson, T.R., Halmos, B., Hausrath, D.J., Hawley, J.E., Hsu, E., Huynh-Le, M., Hwang, C., Jani, C., Jayaraj, A., Johnson, D.B., Kasi, A., Khan, H., Koshkin, V.S., Kuderer, N.M., Kwon, D.H., Lammers, P.E., Li, A., Loaiza-Bonilla, A., Low, C.A., Lustberg, M.B., Lyman, G.H., McKay, R.R., McNair, C., Menon, H., Mesa, R.A., Mico, V., Mundt, D., Nagaraj, G., Nakasone, E.S., Nakayama, J., Nizam, A., Nock, N.L., Park, C., Patel, J.M., Patel, K.G., Peddi, P., Pennell, N.A., Piper-Vallillo, A.J., Puc, M., Ravindranathan, D., Reeves, M.E., Reuben, D.Y., Rosenstein, L., Rosovsky, R.P., Rubinstein, S.M., Salazar, M., Schmidt, A.L., Schwartz, G.K., Shah, M.R., Shah, S.A., Shah, C., Shaya, J.A., Singh, S.R.K., Smits, M., Stockerl-Goldstein, K.E., Stover, D.G., Streckfuss, M., Subbiah, S., Tachiki, L., Tadesse, E., Thakkar, A., Tucker, M.D., Verma, A.K., Vinh, D.C., Weiss, M., Wu, J.T., Wulff-Burchfield, E., Xie, Z., Yu, P.P., Zhang, T., Zhou, A.Y., Zhu, H., Zubiri, L., Shah, D.P., Warner, J.L., Lopes, GdL.
Publicado no Ann Oncol (2021)
“... among patients with cancer and COVID-19. Although further studies are needed, caution may be required...”Publicado no Ann Oncol (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Robinson, Giles W., Rudneva, Vasilisa A., Buchhalter, Ivo, Billups, Catherine A., Waszak, Sebastian M., Smith, Kyle S., Bowers, Daniel C., Bendel, Anne, Fisher, Paul G., Partap, Sonia, Crawford, John R., Hassall, Tim, Indelicato, Daniel J., Boop, Frederick, Klimo, Paul, Sabin, Noah D., Patay, Zoltan, Merchant, Thomas E., Stewart, Clinton F., Orr, Brent A., Korbel, Jan O., Jones, David T.W., Sharma, Tanvi, Lichter, Peter, Kool, Marcel, Korshunov, Andrey, Pfister, Stefan M., Gilbertson, Richard J., Sanders, Robert P., Onar-Thomas, Arzu, Ellison, David W., Gajjar, Amar, Northcott, Paul A.
Publicado no Lancet Oncol (2018)
“...%), respectively (HR 4.17, 95% CI 1.51-11.53, p=0.0028). The 5-year progression-free survival of low-risk iSHH-II...”Publicado no Lancet Oncol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo